 |
 Video: What is a Stock Split?
|
|
|
| Portage Biotech is a clinical stage immune-oncology company focused on overcoming immune resistance. Co. sources, nurtures and develops therapies for a variety of cancers, by funding, implementing product development strategies, clinical counsel/trial design, shared services, financial and project management to enable execution of commercially informed development plans. Co.'s drug development pipeline portfolio encompasses products or technologies based on biology addressing known resistance pathways/mechanisms of check point inhibitors with scientific rationales, including intratumoral delivery, nanoparticles, liposomes, aptamers, and virus-like particles. According to our Portage Biotech stock split history records, Portage Biotech has had 0 splits. | |
|
Portage Biotech (PRTG) has 0 splits in our Portage Biotech stock split history database.
Looking at the Portage Biotech stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Portage Biotech shares, starting with a $10,000 purchase of PRTG, presented on a split-history-adjusted basis factoring in the complete Portage Biotech stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/05/2021 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$17.75 |
|
| End price/share: |
$0.27 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.47% |
|
| Average Annual Total Return: |
-71.59% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$152.66 |
|
| Years: |
3.32 |
|
|
|
|
|
